Sionna Therapeutics (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- March 06, 2024
- Vertical
- Life Sciences
- Funding URL
- View Funding Page
- Funding Amount:
- $182,000,000
Company Info
- Founding Year
- 2019
- Company Description
- Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
- Market
- Cystic Fibrosis Treatments
- Location
- Waltham, MA, USA
- Coinvestors
- Atlas Venture, Cystic Fibrosis Foundation, Enavate Sciences, OrbiMed Advisors, Perceptive Advisors, RA Capital, TPG, Viking Global Investors